Decision Support · Side-by-side

BERG (BPGbio) vs Insitro. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

BERG (BPGbio)

Best overall

Insitro

Neither BERG (BPGbio) nor Insitro is for everyday users—they are enterprise-grade drug discovery platforms for large biotech and pharma. The single biggest difference is that BERG focuses on causal AI from multi-omics data, while Insitro integrates wet-lab experiments with machine learning. For a regular person, neither is usable or affordable.

BERG (BPGbio)

#4528 of 3,826 Web

Insitro

#4288 of 3,826 Web

Scores at a glance

BERG (BPGbio)InsitroPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose BERG (BPGbio) if

You are a large pharmaceutical company with multi-omics data and a budget of millions
You need causal insights into disease mechanisms, not just correlations
You have a dedicated team to handle a 10-step onboarding process over months
You are looking for a partner to co-develop drugs in oncology or metabolic disease

Choose Insitro if

You are a top-20 pharma company wanting to combine AI with your own wet-lab experiments
You have access to iPSC-derived cell models and high-content imaging capabilities
You can commit to a multi-year, multi-million-dollar partnership
You need patient stratification or predictive toxicology for a specific disease area

Key differences

BERG uses causal AI on existing multi-omics data; Insitro generates its own data from lab experiments
BERG has a proprietary human biobank; Insitro relies on iPSC-derived cell models
Insitro has a more famous leadership (Daphne Koller); BERG is less known but has clinical-stage assets
Both have no mobile app, no API, and no self-service pricing
Neither is usable by individuals, small labs, or non-pharma organizations
Both require multi-year partnerships and are not available as a SaaS product

Facts side by side

	BERG (BPGbio)	Insitro
Free plan
Mobile app
API access

BERG (BPGbio): strengths & weaknesses

Uses causal AI to find drug targets, not just correlations
Has a massive proprietary human biobank for validation
Strong pipeline in oncology and other diseases
No mobile app, no API, no public pricing
Requires huge amounts of specialized data you likely don't have
Only accessible via multi-year partnerships, not a self-service tool
Completely irrelevant for everyday tasks like writing or data analysis

Insitro: strengths & weaknesses

Combines wet-lab experiments (iPSC cells) with machine learning
Led by world-class AI expert Daphne Koller
Generates its own high-quality datasets, reducing bias
No mobile app, no API, no public pricing
Extremely selective partnerships only—you can't just sign up
Long development cycles (years) before seeing results
Zero utility for a non-scientist or small business

Common questions

Can I use BERG or Insitro on my phone?

No. Neither tool has a mobile app or any consumer-facing interface. They are enterprise platforms accessed through dedicated partnership teams.

Is BERG (BPGbio) better than Insitro for a small biotech startup?

Neither is suitable for a small startup. Both require massive data, long timelines, and high costs. A small biotech should look at cloud-based drug discovery platforms like Atomwise or Recursion instead.

How much do BERG and Insitro cost?

Neither publishes pricing. Based on their partnership models, expect costs in the millions of dollars per project, making them inaccessible to individuals or small organizations.

Which tool is easier to get started with?

Neither is easy. Both have multi-step onboarding processes that take months and require legal agreements, data integration, and dedicated scientific teams. There is no free trial or demo.

Can I use these tools for non-drug-discovery tasks like writing or data analysis?

No. These tools are purpose-built for drug target identification and biomarker discovery. They cannot help with everyday tasks like summarizing documents, analyzing spreadsheets, or generating text.

BERG and Insitro are powerful but inaccessible drug discovery platforms for large pharma—skip them if you're not a multi-billion-dollar company.

For everyday users, neither BERG nor Insitro is relevant—they are enterprise drug discovery tools for big pharma. If you need AI for personal or small-business tasks, look at consumer tools like ChatGPT, Claude, or Google Gemini instead.

Visit BERG (BPGbio) Visit Insitro

Detail pages: BERG (BPGbio) · Insitro

BERG (BPGbio)

Insitro

Free plan

Mobile app

API access